CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 30 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,073 | -97.4% | 28,400 | -95.7% | 0.00% | -100.0% |
| Q2 2023 | $391,611 | -6.7% | 664,766 | -9.7% | 0.00% | -25.0% |
| Q1 2023 | $419,901 | -18.3% | 736,027 | -4.5% | 0.00% | 0.0% |
| Q4 2022 | $513,857 | -42.8% | 770,400 | +25.2% | 0.00% | -50.0% |
| Q3 2022 | $898,000 | +35.2% | 615,200 | +0.1% | 0.01% | +33.3% |
| Q2 2022 | $664,000 | -57.7% | 614,480 | +19.4% | 0.01% | -57.1% |
| Q1 2022 | $1,570,000 | +25.2% | 514,780 | +59.7% | 0.01% | +27.3% |
| Q4 2021 | $1,254,000 | +128.8% | 322,373 | +210.2% | 0.01% | +83.3% |
| Q3 2021 | $548,000 | -9.7% | 103,925 | +1.4% | 0.01% | 0.0% |
| Q2 2021 | $607,000 | -37.6% | 102,525 | -25.0% | 0.01% | -50.0% |
| Q1 2021 | $972,000 | – | 136,725 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 458,466 | $1,783,000 | 0.72% |
| Affinity Asset Advisors, LLC | 400,000 | $1,548,000 | 0.56% |
| Sio Capital Management, LLC | 422,598 | $1,644,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,977,000 | 0.22% |
| Ikarian Capital, LLC | 99,422 | $385,000 | 0.06% |
| PURA VIDA INVESTMENTS, LLC | 102,324 | $398,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 322,373 | $1,254,000 | 0.01% |
| NEXT Financial Group, Inc | 23,852 | $93,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $895,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 67,600 | $263,000 | 0.00% |